Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease

J A Tibble, G Sigthorsson, R Foster, I Forgacs, I Bjarnason

Research output: Contribution to journalArticlepeer-review

363 Citations (Scopus)

Abstract

Background & Aims: Differentiating symptoms of irritable bowel syndrome (IBS) from those of organic intestinal disease is a familiar problem for physicians. The aim of this study was to assess the sensitivity, specificity, and odds ratios (ORs) of fecal calprotectin, small intestinal permeability, Rome I criteria, and laboratory markers of inflammation (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], blood count) in distinguishing organic from nonorganic intestinal disease. Methods: A total of 602 new referrals to a gastroenterology clinic who had symptoms suggestive of IBS or organic intestinal disease were studied for these parameters. All patients underwent invasive imaging (barium/endoscopic examination) and other investigations as appropriate, with physicians blinded to the results of fecal calprotectin and intestinal permeability. Results: A total of 263 patients were diagnosed with organic disease and 339 with IBS. At 10 mg/L, the sensitivity and specificity of calprotectin for organic disease were 89% and 79%, respectively, and that of intestinal permeability for small intestinal disease were 63% and 87% respectively. Sensitivity of positive Rome criteria for 113 was 85% with a specificity of 71%. An abnormal calprotectin test had an OR for disease of 27.8 (95% confidence interval [CI], 17.6-43.7; P <0.0001) compared with ORs of 4.2 (95% CI, 2.9-6.1; P <0.0001) and 3.2 (95% CI, 2.2-4.6; P <0.0001) for elevated CRP and ESR values. An abnormal permeability test gave an OR of 8.9 (95% CI, 5.8-14.0; P <0.0001) for small intestinal disease. The OR for IBS with positive Rome criteria was 13.3 (95% CI, 8.9-20.0). Conclusions: Fecal calprotectin, intestinal permeability, and positive Rome I criteria provide a safe and noninvasive means of helping differentiate between patients with organic and nonorganic intestinal disease.
Original languageEnglish
Pages (from-to)450 - 460
Number of pages11
JournalGastroenterology
Volume123
Issue number2
DOIs
Publication statusPublished - 2002

Fingerprint

Dive into the research topics of 'Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease'. Together they form a unique fingerprint.

Cite this